X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2059) 2059
Book Review (306) 306
Publication (100) 100
Book Chapter (9) 9
Book / eBook (2) 2
Conference Proceeding (2) 2
Dissertation (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1857) 1857
index medicus (1727) 1727
female (1074) 1074
male (961) 961
vasculitis - chemically induced (732) 732
middle aged (716) 716
vasculitis (713) 713
adult (625) 625
aged (463) 463
vasculitis, leukocytoclastic, cutaneous - chemically induced (423) 423
animals (285) 285
rheumatology (272) 272
abridged index medicus (259) 259
vasculitis - pathology (232) 232
therapy (217) 217
medicine, general & internal (215) 215
dermatology (177) 177
propylthiouracil - adverse effects (154) 154
vasculitis - immunology (153) 153
diagnosis, differential (147) 147
adolescent (146) 146
vasculitis, leukocytoclastic, cutaneous - pathology (141) 141
treatment outcome (140) 140
antithyroid agents - adverse effects (138) 138
drug eruptions - etiology (132) 132
biopsy (128) 128
skin - pathology (115) 115
propylthiouracil (108) 108
risk factors (105) 105
mice (103) 103
vasculitis - diagnosis (103) 103
antirheumatic agents - adverse effects (102) 102
rats (101) 101
immunology (99) 99
anca (98) 98
pharmacology & pharmacy (98) 98
antibodies, antineutrophil cytoplasmic - blood (97) 97
disease (97) 97
inflammation (96) 96
leukocytoclastic vasculitis (95) 95
urology & nephrology (95) 95
child (93) 93
cocaine (93) 93
vasculitis - drug therapy (92) 92
arthritis, rheumatoid - drug therapy (91) 91
autoantibodies (90) 90
levamisole - adverse effects (89) 89
medicine & public health (86) 86
vasculitis - complications (86) 86
necrosis (85) 85
rheumatoid-arthritis (84) 84
immunosuppressive agents - therapeutic use (83) 83
aged, 80 and over (82) 82
vasculitis, leukocytoclastic, cutaneous - diagnosis (82) 82
graves disease - drug therapy (80) 80
clinical neurology (78) 78
glomerulonephritis (78) 78
immunosuppressive agents - adverse effects (78) 78
anti-bacterial agents - adverse effects (76) 76
time factors (75) 75
retrospective studies (74) 74
purpura - chemically induced (73) 73
antineutrophil cytoplasmic antibodies (68) 68
pathology (68) 68
cocaine - adverse effects (67) 67
drug therapy, combination (67) 67
patient (67) 67
systemic vasculitis (67) 67
glomerulonephritis - chemically induced (66) 66
peroxidase - immunology (66) 66
young adult (66) 66
care and treatment (65) 65
drug contamination (65) 65
follow-up studies (65) 65
cutaneous vasculitis (64) 64
diagnosis (64) 64
complications and side effects (63) 63
hematology (62) 62
anti-neutrophil cytoplasmic antibody-associated vasculitis - chemically induced (61) 61
disease models, animal (61) 61
antineoplastic agents - adverse effects (60) 60
antibodies, antineutrophil cytoplasmic - immunology (59) 59
antibodies, monoclonal - adverse effects (59) 59
cocaine-related disorders - complications (59) 59
antibodies (58) 58
dermatology & venereal diseases (58) 58
levamisole (58) 58
skin (57) 57
drugs (56) 56
oncology (56) 56
drug hypersensitivity - etiology (55) 55
infliximab (55) 55
lupus erythematosus, systemic - chemically induced (55) 55
neutropenia (55) 55
toxicology (55) 55
drug therapy (54) 54
rheumatoid arthritis (54) 54
antineutrophil cytoplasmic antibody (53) 53
arthritis (53) 53
etanercept (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1822) 1822
French (87) 87
Spanish (48) 48
German (36) 36
Japanese (25) 25
Chinese (11) 11
Russian (11) 11
Polish (8) 8
Italian (6) 6
Hebrew (4) 4
Portuguese (3) 3
Danish (2) 2
Dutch (2) 2
Croatian (1) 1
Hungarian (1) 1
Korean (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicine, ISSN 0025-7974, 07/2007, Volume 86, Issue 4, pp. 242 - 251
Journal Article
Circulation, ISSN 0009-7322, 09/2011, Volume 124, Issue 12, pp. 1370 - 1381
Background-Angiotensin II (ATII), a potent vasoconstrictor, causes hypertension, promotes infiltration of myelomonocytic cells into the vessel wall, and... 
blood vessels | inflammation | hypertension | angiotensin II | oxidative stress | MACROPHAGE INFILTRATION | CARDIAC & CARDIOVASCULAR SYSTEMS | ENDOTHELIAL DYSFUNCTION | SUPEROXIDE-PRODUCTION | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE | CELL-LINEAGE-ABLATION | BLOOD-PRESSURE | IN-VITRO | MOUSE MODEL | PERIPHERAL VASCULAR DISEASE | MICE | Vasculitis - metabolism | Reactive Oxygen Species - metabolism | Muscle, Smooth, Vascular - metabolism | Oxidative Stress - physiology | Muscle, Smooth, Vascular - immunology | Male | Monocytes - metabolism | Monocytes - immunology | Muramidase - immunology | Vasculitis - immunology | Respiratory Burst - physiology | Hypertension - chemically induced | Gene Expression - immunology | Neutrophils - metabolism | Vasculitis - chemically induced | Macrophages - immunology | Endothelium, Vascular - immunology | Vasoconstrictor Agents - pharmacology | Angiotensin II - pharmacology | Mice, Inbred C57BL | Muramidase - genetics | Receptors, Chemokine - metabolism | Neutrophils - immunology | Mice, Transgenic | Hypertension - immunology | Muramidase - metabolism | Hypertension - metabolism | Macrophages - metabolism | Animals | Endothelium, Vascular - metabolism | Mice | CD11b Antigen - metabolism | Nitric Oxide - metabolism | Hypertension | Blood circulation disorders | Oxidative stress | Angiotensin | Physiological aspects | Development and progression | Research | Lysozyme | Index Medicus | Abridged Index Medicus
Journal Article
Circulation Research, ISSN 0009-7330, 07/2010, Volume 107, Issue 2, pp. 263 - 270
RATIONALE:We have previously found that T lymphocytes are essential for development of angiotensin II–induced hypertension; however, the mechanisms responsible... 
vascular inflammation | T cells | hypertension | central nervous system | CARDIAC & CARDIOVASCULAR SYSTEMS | AV3V | RATS | INFUSION | BLOOD-PRESSURE | RECEPTOR STIMULATION | REDUCTION | PERIPHERAL VASCULAR DISEASE | CENTRAL-NERVOUS-SYSTEM | DYSFUNCTION | HEMATOLOGY | EXTRACELLULAR-SUPEROXIDE DISMUTASE | CELL | Blood Pressure | Vasculitis - metabolism | Third Ventricle - injuries | Vasculitis - physiopathology | Homeodomain Proteins - metabolism | Antihypertensive Agents - administration & dosage | Receptors, Antigen, T-Cell, alpha-beta - immunology | Adoptive Transfer | Vasculitis - prevention & control | Genes, T-Cell Receptor beta | Third Ventricle - physiopathology | T-Lymphocytes - transplantation | Vasculitis - immunology | Vasculitis - genetics | Time Factors | T-Lymphocytes - drug effects | Hypertension - chemically induced | Superoxides - metabolism | Hypertension - prevention & control | Hypertension - genetics | Angiotensin II | Vasculitis - chemically induced | Disease Models, Animal | Administration, Oral | Mice, Inbred C57BL | Mice, Transgenic | Hypertension - immunology | Homeodomain Proteins - genetics | Hypertension - physiopathology | Hypertension - metabolism | Mice, Knockout | Hydralazine - administration & dosage | Animals | Lymphocyte Activation - drug effects | Third Ventricle - immunology | Genes, T-Cell Receptor alpha | T-Lymphocytes - immunology | Mice | Norepinephrine | Index Medicus | Hypertension
Journal Article
Hypertension, ISSN 0194-911X, 02/2012, Volume 59, Issue 2, pp. 324 - 330
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Summary Background Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a... 
Infectious Disease | INFECTIOUS DISEASES | MARBURG VIRUS | ACTIVATION | DUCK RUBELLA VACCINE | IMMUNE-RESPONSES | PROTECTS NONHUMAN-PRIMATES | VESICULAR STOMATITIS | GLYCOPROTEINS | INFECTION | FEVER | AGE | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health | Index Medicus
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 04/2018, Volume 188, pp. 131 - 140
Journal Article
Arthritis and Rheumatology, ISSN 2326-5191, 11/2017, Volume 69, Issue 11, pp. 2175 - 2186
Journal Article
Ophthalmology, ISSN 0161-6420, 07/2015, Volume 122, Issue 7, pp. 1438 - 1451
Journal Article